CRT Capital Cuts Tenet Healthcare to Fair Value (THC)

By admin | 6 years ago

Tenet Healthcare (NYSE: THC) was downgraded by research analysts at CRT Capital from a “buy” rating to a “fair value” rating in a report released on Tuesday.

Shares of Tenet Healthcare opened at 4.75 on Tuesday. Tenet Healthcare has a 52 week low of $3.46 and a 52 week high of $6.95. The company has a market cap of $1.966 billion and a P/E ratio of 53.89.

Tenet Healthcare last announced its earnings results on Tuesday, May 8th. The company reported $0.13 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.10 by $0.03. The company’s quarterly revenue was up 2.2% on a year-over-year basis. On average, analysts predict that Tenet Healthcare will post $0.07 earnings per share next quarter.

A number of other firms have also recently commented on THC. Analysts at Zacks reiterated a “neutral” rating on shares of Tenet Healthcare in a research note to investors on Wednesday, May 2nd. They now have a $5.50 price target on the stock. Analysts at Jefferies Group (NYSE: JEF) raised their price target on shares of Tenet Healthcare to $6.50 in a research note to investors on Friday, March 16th.

Tenet Healthcare Corporation (Tenet) is an investor-owned health care services company, which principally operates general hospitals and related ancillary health care businesses.

About the author